In a large dataset comprising gene expression data from 2487 pediatric cancer patients23, CDK12 expression was slightly but significantly higher in AML patients (n = 320) compared to all other pediatric cancer entities (Fig. 6A). This evidence concerns the gene CDK12 and cancer.